Literature DB >> 26493621

Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients.

Maria Fusaro1, Maurizio Gallieni2,3, Paola Rebora4, Maria Antonietta Rizzo2,3, Maria Carmen Luise5, Hilary Riva5, Silvio Bertoli6, Ferruccio Conte7, Andrea Stella5,8, Patrizia Ondei9, Emanuela Rossi4, Maria Grazia Valsecchi4, Antonio Santoro10, Simonetta Genovesi11,12.   

Abstract

BACKGROUND/AIMS: Vascular calcifications (VCs) and fractures are major complications of chronic kidney disease. Hemodialysis patients have a high prevalence of atrial fibrillation (AF) and an increased risk of thromboembolism, which should be prevented with warfarin, a drug potentially causing increased risk of VCs and fractures. Aim of this study is evaluating, in hemodialysis patients with and without AF, the prevalence of VCs and fractures, as well as identifying the associated risk factors.
METHODS: A total of 314 hemodialysis patients were recruited, 101 with documented AF and 213 without AF. Comorbidities, chronic kidney disease mineral and bone disorder blood tests and therapies were collected. Vertebral quantitative morphometry was carried out centrally for the detection of fractures, defined as vertebral body reduction by ≥20 %. In the same radiograph, the length of aortic calcification was also measured. Logistic regression models were applied for evaluating the independent predictors of presence of VCs and vertebral fractures.
RESULTS: In our population VCs were very common (>85 %). Severe VCs (>10 cm) were more common in patients with AF (76 %) than in patients without (33 %). Vertebral fractures were present in 54 % of patients. Multivariable analysis showed that AF (OR 5.41, 95 % CI 2.30-12.73) and 25(OH) vitamin D <20 ng/mL (OR 2.05, 95 % CI 1.10-3.83) were independent predictors of VCs. Age (OR 1.04/year, 95 % CI 1.01-1.07) and male gender (OR 1.76, 95 % CI 1.07-2.90) predicted vertebral fractures.
CONCLUSIONS: Hemodialysis patients had an elevated prevalence of severe VCs, especially when affected by AF. Low vitamin D levels were strongly associated with severe VCs. Prevalence of vertebral fractures was also remarkably high and associated with older age and male gender.

Entities:  

Keywords:  Atrial fibrillation; Fractures; Hemodialysis; Vascular calcifications; Vitamin D; Warfarin

Mesh:

Substances:

Year:  2015        PMID: 26493621     DOI: 10.1007/s40620-015-0236-7

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  30 in total

1.  Reproducibility of a semi-automatic method for 6-point vertebral morphometry in a multi-centre trial.

Authors:  Giuseppe Guglielmi; Luca Pio Stoppino; Maria Grazia Placentino; Francesco D'Errico; Francesco Palmieri
Journal:  Eur J Radiol       Date:  2007-12-19       Impact factor: 3.528

2.  Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.

Authors:  Jenny I Shen; Maria E Montez-Rath; Colin R Lenihan; Mintu P Turakhia; Tara I Chang; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2015-07-07       Impact factor: 8.860

3.  Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients.

Authors:  Bob Weijs; Yuri Blaauw; Roger J M W Rennenberg; Leon J Schurgers; Carl C M M Timmermans; Laurent Pison; Robby Nieuwlaat; Leonard Hofstra; Abraham A Kroon; Joachim Wildberger; Harry J G M Crijns
Journal:  Eur Heart J       Date:  2011-07-20       Impact factor: 29.983

4.  Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.

Authors:  Guillaume Jean; Eric Bresson; Jean-Claude Terrat; Thierry Vanel; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Charles Chazot
Journal:  Nephrol Dial Transplant       Date:  2008-10-13       Impact factor: 5.992

5.  Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.

Authors:  Kristin M McCabe; Sarah L Booth; Xueyan Fu; Navid Shobeiri; Judith J Pang; Michael A Adams; Rachel M Holden
Journal:  Kidney Int       Date:  2013-01-23       Impact factor: 10.612

6.  Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients.

Authors:  Maria Fusaro; Giovanni Tripepi; Marianna Noale; Mario Plebani; Martina Zaninotto; Antonio Piccoli; Agostino Naso; Davide Miozzo; Sandro Giannini; Marco Avolio; Annalisa Foschi; Maria Antonietta Rizzo; Maurizio Gallieni
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

Review 7.  Mechanistic insights into vascular calcification in CKD.

Authors:  Rukshana Shroff; David A Long; Catherine Shanahan
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

8.  J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis.

Authors:  J C Witteman; D E Grobbee; H A Valkenburg; A M van Hemert; T Stijnen; H Burger; A Hofman
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

Review 9.  Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.

Authors:  Khai P Ng; Nicola C Edwards; Gregory Y H Lip; Jonathan N Townend; Charles J Ferro
Journal:  Am J Kidney Dis       Date:  2013-06-05       Impact factor: 8.860

10.  High rates of death and hospitalization follow bone fracture among hemodialysis patients.

Authors:  Francesca Tentori; Keith McCullough; Ryan D Kilpatrick; Brian D Bradbury; Bruce M Robinson; Peter G Kerr; Ronald L Pisoni
Journal:  Kidney Int       Date:  2013-07-31       Impact factor: 10.612

View more
  7 in total

1.  Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.

Authors:  Juan C Ramirez-Sandoval; Mauricio Arvizu-Hernandez; Cristino Cruz; Barbara Vazquez-Cantu; Luis J Rojas-Concha; Luis Tamez; Fagundo Reynerio; F Enrique Gomez; Ricardo Correa-Rotter
Journal:  J Nephrol       Date:  2019-03-19       Impact factor: 3.902

2.  Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus.

Authors:  Maria Fusaro; Maurizio Gallieni; Andrea Aghi; Maria Antonietta Rizzo; Giorgio Iervasi; Thomas L Nickolas; Fabrizio Fabris; Maria Cristina Mereu; Sandro Giannini; Stefania Sella; Andrea Giusti; Annalisa Pitino; Graziella D'Arrigo; Maurizio Rossini; Davide Gatti; Maura Ravera; Luca Di Lullo; Antonio Bellasi; Giuliano Brunori; Antonio Piccoli; Giovanni Tripepi; Mario Plebani
Journal:  J Nephrol       Date:  2019-02-13       Impact factor: 3.902

3.  Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.

Authors:  Simonetta Genovesi; Paola Rebora; Maurizio Gallieni; Andrea Stella; Fabio Badiali; Ferruccio Conte; Sonia Pasquali; Silvio Bertoli; Patrizia Ondei; Giuseppe Bonforte; Claudio Pozzi; Emanuela Rossi; Maria Grazia Valsecchi; Antonio Santoro
Journal:  J Nephrol       Date:  2016-11-11       Impact factor: 3.902

Review 4.  Vitamin D in Chronic Kidney Disease and Dialysis Patients.

Authors:  Guillaume Jean; Jean Claude Souberbielle; Charles Chazot
Journal:  Nutrients       Date:  2017-03-25       Impact factor: 5.717

5.  Hypovitaminosis D in chronic kidney disease.

Authors:  Sérgio Gardano Elias Bucharles; Fellype Carvalho Barreto; Rodrigo Bueno de Oliveira
Journal:  J Bras Nefrol       Date:  2021-12-03

6.  Vitamin K antagonists and cardiovascular calcification: A systematic review and meta-analysis.

Authors:  Nina D Kosciuszek; Daniel Kalta; Mohnish Singh; Olga V Savinova
Journal:  Front Cardiovasc Med       Date:  2022-08-19

Review 7.  The Status and Research Progress on Vitamin D Deficiency and Atrial Fibrillation.

Authors:  Lizhan Bie
Journal:  Braz J Cardiovasc Surg       Date:  2019-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.